Delivery Order HHSF223201310058I-HHSF22301008T
Award Date
6/30/17
Potential Completion Date
8/2/18
Potential Value
$1.4M
Federal Agency
Food and Drug Administration
Awardee
Pointcross, Inc.
Ultimate Awardee
Not listed
NAICS Category
541511 - Custom Computer Programming Services
PSC Category
D324 - It And Telecom- Business Continuity
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded a definitive contract valued at $8.5 million to Pointcross, Inc. of Silver Spring, Maryland. The contract is for Risk Modeling and Simulation Tool software platform license maintenance, upgrades, and support over a five-year period. Pointcross will provide ongoing operations, maintenance, and training for the agency's Risk Modeling and Simulation Tool, which toxicologists use to review nonclinical study data. The...
This is a delivery order contract awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services, to Pointcross, Inc., a small business contractor. The contract is for operations and maintenance, as well as system enhancements, for the FDA's Risk Modeling and Simulation Tool. The contract has a ceiling value of $1,293,424.00 and a completion date of August 2, 2017. It is a firm fixed-price contract awarded non-competitively as a...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm-fixed-price delivery order contract worth $952,966.00 to Pointcross, Inc., a for-profit organization, to provide a Risk Modeling and Simulation Tool (RMST) for the Center for Tobacco Products. This non-set-aside contract is a follow-on to an existing agreement, allowing Pointcross to continue providing software platform license maintenance, upgrades, and support services for the FDA's toxicology...
The Department of Health and Human Services Food and Drug Administration awarded a Firm Fixed Price contract to Pointcross, Inc., a for-profit corporation, for a Risk Modeling and Simulation Tool (RMST) software platform license maintenance, upgrades, and support services. The contract has a potential value of $719,217.00 and a completion date of August 16, 2020. The award was made on a sole-source basis as a follow-on to an existing contract, with no set-aside designation. Pointcross also holds...
The U.S. Food and Drug Administration (FDA) awarded a $1,000,060.00 firm fixed-price delivery order contract to Pointcross, Inc., a small business located in Foster City, California. The contract is for risk modeling and simulation tool software platform license maintenance, upgrades, and support services over a period ending on September 15, 2016. This is a follow-on award to an existing contract, with no set-aside designation. Pointcross also holds a $500,000 Multiple Award Schedule contract...
This is a $973,595.78 firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Pointcross, Inc., a for-profit organization based in Foster City, California. The contract is for the operation and maintenance of the FDA's National Integrated Monitoring System (NIMS), including production support and training services. The contract has no set-aside designation and was awarded non-competitively as a follow-on to an existing contract. Pointcross also holds a Multiple Award...
The U.S. Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order to Simulations Plus Inc., a for-profit software company specializing in pharmaceutical modeling and simulation. The contract, valued at $109,798.77, is for the purchase of 50 GastroPlus licenses, 30 IVIVCPlus module licenses, and 30 PBPK Plus licenses. The contract has no set-aside designation and is not associated with a larger contract vehicle. Simulations Plus has previously provided similar software...
This firm-fixed price purchase order contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Certara UK LIMITED, doing business as Certara, a for-profit limited liability company. The $164,400 contract provides annual licenses and maintenance support for Certara's SIMCYP physiologically-based pharmacokinetic modeling software. The software is used by the FDA's Office of Clinical Pharmacology to review submissions from pharmaceutical sponsors,...
This federal contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Certara USA Inc., doing business as Tripos (DE), is for $83,806.57 to provide Certara Phoenix software licenses for pharmacokinetic modeling and simulation. The contract is a firm fixed-price purchase order with a completion date of August 31, 2026. Certara is a technology-enabled drug development and drug safety consultancy that has received numerous prior federal contract...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Simulations Plus Inc., a prime contractor that specializes in drug discovery and development simulation and modeling software. The $130,000 contract is for the extension and validation of Simulations Plus' GastroPlus ocular compartmental absorption and transit model. There is no set-aside designation for this contract. Simulations Plus has received over $5 million in...